Nondisplaceable Binding Is a Potential Confounding Factor in 11C-PBR28 Translocator Protein PET Studies
Conclusion: Our findings suggest that in TSPO PET studies, nondisplaceable binding can differ between patient groups and conditions and should therefore be considered.
Source: Journal of Nuclear Medicine - Category: Nuclear Medicine Authors: Laurell, G. L., Plaven-Sigray, P., Jucaite, A., Varrone, A., Cosgrove, K. P., Svarer, C., Knudsen, G. M., Karolinska Schizophrenia Project Consortium, Ogden, R. T., Zanderigo, F., Cervenka, S., Hillmer, A. T., Schain, M. Tags: Clinical Source Type: research
More News: Alcoholism | Brain | Neurology | Nuclear Medicine | Parkinson's Disease | Schizophrenia | Study